Abstract | BACKGROUND AND AIMS: METHODS AND RESULTS: CONCLUSION:
|
Authors | Laura M Tanner, Harri Niinikoski, Kirsti Näntö-Salonen, Olli Simell |
Journal | Journal of inherited metabolic disease
(J Inherit Metab Dis)
Vol. 33 Suppl 3
Pg. S145-50
(Dec 2010)
ISSN: 1573-2665 [Electronic] United States |
PMID | 20177788
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers
- CST3 protein, human
- Cholesterol, HDL
- Cystatin C
- Heptanoic Acids
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Pyrroles
- Triglycerides
- Cholesterol
- Atorvastatin
- Simvastatin
|
Topics |
- Adolescent
- Adult
- Amino Acid Metabolism, Inborn Errors
(blood, complications, diagnosis, therapy)
- Atorvastatin
- Biomarkers
(blood)
- Child
- Child, Preschool
- Cholesterol
(blood)
- Cholesterol, HDL
(blood)
- Cystatin C
(metabolism)
- Disease Progression
- Female
- Finland
- Heptanoic Acids
(therapeutic use)
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
(therapeutic use)
- Hyperlipidemias
(blood, diagnosis, drug therapy, etiology)
- Male
- Middle Aged
- Pyrroles
(therapeutic use)
- Retrospective Studies
- Risk Factors
- Simvastatin
(therapeutic use)
- Time Factors
- Treatment Outcome
- Triglycerides
(blood)
- Young Adult
|